Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Epidemiology major salivary gland tumour in Eastern Indonesia

Elvis Jeferson, Septiman, Muhammad Faruk.




Abstract
Cited by 0 Articles

Introduction: Salivary glands tumours are relatively rare to find. There is still no adequate data about the incidence of salivary gland tumours in Eastern Indonesia. The main objective of this research was to evaluate the patient profile, location of tumour, histopathology, and management of salivary glands tumours.
Methods: Descriptive retrospective used from January 2014 to December 2018, patients in Eastern Indonesia.

Results: There are 47 patients with salivary glands tumours. Females were 55,3% and male were 44,7%. By age groups found that 60 years for 27,7%. Based on the histopathology classification, pleomorphic adenoma for 34%, Whartin tumour for 2.1%, mucoepidermoid carcinoma for 29,8%, adenocarcinoma for 6,4%, Acinic cell carcinoma for 6,4%. Cystic adenoid for 6,4%, Epithelial carcinoma for 14,8%. Based on the location of the tumour’s appearance, parotid gland for 85,1%, sub-mandibular gland for 8,6%, sublingual glands for 6,3%. Based by the incidences, first year for 25,5%, second year for 12,8%, third year for 21,3%, fourth year for 12,8%, fifth year for 27,6%.

Conclusion: Salivary gland tumours in our institution more common in women, developed in people aged 31-45 years, the parotid gland is the most common site and the most common malignant tumours are mucoepidermoid carcinoma.

Key words: Salivary glands tumors, Age, Gender, Histopathology






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.